{"nctId":"NCT05256017","briefTitle":"Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects","startDateStruct":{"date":"2021-12-30","type":"ACTUAL"},"conditions":["Trypanosomiasis, African","Trypanosoma Brucei Gambiense; Infection","Sleeping Sickness"],"count":1208,"armGroups":[{"label":"Acoziborole","type":"EXPERIMENTAL","interventionNames":["Drug: Acoziborole"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Acoziborole","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Signed the informed consent form (ICF)\n* Male or female\n* 15 years of age or older\n* Card agglutination test for trypanosomiasis (CATT) test or HAT sero-K-set rapid diagnostic test (RDT) positive\n* Parasitology negative (in blood and/or lymph node aspirate \\[if lymphadenopathy is present\\])\n* Karnofsky performance status above 70\n* Able to ingest oral tablets\n* Known address and/or contact details provided\n* Able to comply with the schedule of follow-up visits and other requirements of the study\n* Agreement to be hospitalized upon enrolment for at least 5 days (in order to receive in-ward post-treatment observational follow-up through the first 5 days after treatment)\n* Agreement to not take part in any other clinical trials during the participation in this study\n* For women of childbearing potential:\n\n  * Agreed to have protected sexual relations to avoid becoming pregnant from enrolment up to 3 months after dosing (contraceptive protection was advised and offered at no cost)\n  * Negative urine pregnancy tests (before dosing at site level)\n\nExclusion Criteria:\n\n* Individuals parasitologically confirmed in blood and/or lymph\n* Previously treated for g-HAT\n* Severe malnutrition, defined as body mass index (BMI) \\<16 kg/m\\^2\n* Pregnant or breast-feeding women\n* For women of childbearing potential:\n\n  * Urine pregnancy test positive\n  * Did not accept contraceptive protection (i.e. condom or sexual abstinence) from enrolment up to 3 months after dosing\n* Clinically significant medical condition and/or abnormal laboratory results that could, in the opinion of the Investigator, jeopardize the participant's safety or participation in the study\n\nAdditional exclusion criteria for the TrypSkin exploratory sub-study:\n\n* Rejection to participate in the exploratory sub-study in the signed ICF\n* Known diabetes mellitus\n* Known hemophilia","healthyVolunteers":false,"sex":"ALL","minimumAge":"15 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Occurrence of Any TEAEs","description":"Occurrence and excess rate (95% CI) of any TEAEs.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"195","spread":null},{"groupId":"OG001","value":"69","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Malaria","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Acarodermatitis","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Abdominal Pain","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Enteritis","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Nausea","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Gastritis","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Headache","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Fatigue","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs - Blood Potassium Increased","description":"Occurrence and excess rate (95% CI) of common TEAEs (by PT, for PTs reported in ≥1% of participants in either arm).","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of TEAEs by Period of Occurrence","description":"Occurrence and excess rate (95% CI) of any TEAEs, by period of occurrence.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null},{"groupId":"OG001","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"106","spread":null},{"groupId":"OG001","value":"45","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of Serious TEAEs","description":"Occurrence and excess rate (95% CI) of any serious TEAEs.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Occurrence of Adverse Events (AEs)","description":"Occurrence of any Adverse Event from Inform Consent signature to 4 month follow-up visit.\n\nOf note, all AEs reported during this study were TEAEs.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"195","spread":null},{"groupId":"OG001","value":"69","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Alanine Aminotransferase","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.6","spread":"7.90"},{"groupId":"OG001","value":"20.6","spread":"9.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.9","spread":"9.10"},{"groupId":"OG001","value":"24.9","spread":"13.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.2","spread":"7.87"},{"groupId":"OG001","value":"19.5","spread":"11.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.8","spread":"8.05"},{"groupId":"OG001","value":"20.0","spread":"6.71"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Albumin","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.22","spread":"0.471"},{"groupId":"OG001","value":"3.23","spread":"0.433"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.12","spread":"0.434"},{"groupId":"OG001","value":"3.13","spread":"0.414"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.27","spread":"0.413"},{"groupId":"OG001","value":"3.24","spread":"0.391"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.22","spread":"0.416"},{"groupId":"OG001","value":"3.21","spread":"0.398"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Alkaline Phosphatase","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"99.8","spread":"46.71"},{"groupId":"OG001","value":"101.8","spread":"52.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.9","spread":"40.18"},{"groupId":"OG001","value":"95.7","spread":"46.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96.6","spread":"47.88"},{"groupId":"OG001","value":"98.3","spread":"53.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98.6","spread":"44.85"},{"groupId":"OG001","value":"98.1","spread":"49.90"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Aspartate Aminotransferase","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"32.8","spread":"10.20"},{"groupId":"OG001","value":"32.7","spread":"12.41"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"33.8","spread":"11.21"},{"groupId":"OG001","value":"37.2","spread":"19.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.0","spread":"9.50"},{"groupId":"OG001","value":"32.6","spread":"30.32"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.8","spread":"10.95"},{"groupId":"OG001","value":"31.1","spread":"8.51"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Calcium","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.314","spread":"0.1341"},{"groupId":"OG001","value":"2.322","spread":"0.1216"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.279","spread":"0.1681"},{"groupId":"OG001","value":"2.328","spread":"0.1550"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.305","spread":"0.1499"},{"groupId":"OG001","value":"2.298","spread":"0.1904"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.297","spread":"0.1399"},{"groupId":"OG001","value":"2.297","spread":"0.1514"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Chloride","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"105.3","spread":"3.05"},{"groupId":"OG001","value":"105.3","spread":"2.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.2","spread":"3.22"},{"groupId":"OG001","value":"105.2","spread":"3.53"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"105.1","spread":"3.04"},{"groupId":"OG001","value":"105.0","spread":"3.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"104.8","spread":"2.89"},{"groupId":"OG001","value":"104.8","spread":"3.18"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Creatinine","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.84","spread":"0.238"},{"groupId":"OG001","value":"0.84","spread":"0.230"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.83","spread":"0.256"},{"groupId":"OG001","value":"0.81","spread":"0.233"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":"0.230"},{"groupId":"OG001","value":"0.81","spread":"0.220"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":"0.227"},{"groupId":"OG001","value":"0.80","spread":"0.223"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Glucose","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88.581","spread":"19.9540"},{"groupId":"OG001","value":"87.087","spread":"11.3391"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"89.801","spread":"14.4784"},{"groupId":"OG001","value":"89.410","spread":"9.9699"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.715","spread":"16.4756"},{"groupId":"OG001","value":"90.207","spread":"10.8139"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.226","spread":"24.4440"},{"groupId":"OG001","value":"89.225","spread":"10.2205"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Potassium","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.58","spread":"0.537"},{"groupId":"OG001","value":"4.60","spread":"0.572"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.67","spread":"0.607"},{"groupId":"OG001","value":"4.59","spread":"0.559"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.61","spread":"0.589"},{"groupId":"OG001","value":"4.60","spread":"0.636"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.59","spread":"0.540"},{"groupId":"OG001","value":"4.61","spread":"0.550"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Sodium","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"136.7","spread":"3.39"},{"groupId":"OG001","value":"136.7","spread":"3.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137.2","spread":"3.75"},{"groupId":"OG001","value":"137.1","spread":"3.97"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137.2","spread":"3.41"},{"groupId":"OG001","value":"137.1","spread":"3.94"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"137.1","spread":"3.36"},{"groupId":"OG001","value":"137.0","spread":"3.38"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Total Bilirubin","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.879","spread":"0.3457"},{"groupId":"OG001","value":"0.869","spread":"0.3469"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.739","spread":"0.2957"},{"groupId":"OG001","value":"0.809","spread":"0.2506"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.818","spread":"0.2641"},{"groupId":"OG001","value":"0.884","spread":"0.2591"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.887","spread":"0.318"},{"groupId":"OG001","value":"0.902","spread":"0.2937"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Bicarbonate","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.5","spread":"2.46"},{"groupId":"OG001","value":"27.5","spread":"2.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.5","spread":"2.39"},{"groupId":"OG001","value":"28.2","spread":"2.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.0","spread":"2.50"},{"groupId":"OG001","value":"27.7","spread":"2.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.0","spread":"2.48"},{"groupId":"OG001","value":"27.9","spread":"2.58"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Total Protein","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.63","spread":"0.589"},{"groupId":"OG001","value":"7.65","spread":"0.565"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.46","spread":"0.566"},{"groupId":"OG001","value":"7.61","spread":"0.584"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.55","spread":"0.547"},{"groupId":"OG001","value":"7.59","spread":"0.583"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.54","spread":"0.573"},{"groupId":"OG001","value":"7.57","spread":"0.591"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Biochemistry Parameter: Blood Urea Nitrogen","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.434","spread":"2.5471"},{"groupId":"OG001","value":"7.415","spread":"2.6550"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.402","spread":"2.6432"},{"groupId":"OG001","value":"8.358","spread":"2.4459"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.951","spread":"2.2998"},{"groupId":"OG001","value":"6.820","spread":"2.5365"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.501","spread":"2.3841"},{"groupId":"OG001","value":"7.383","spread":"2.2759"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hematology Parameter: Hemoglobin","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.09","spread":"1.706"},{"groupId":"OG001","value":"13.10","spread":"1.554"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.57","spread":"1.627"},{"groupId":"OG001","value":"12.95","spread":"1.513"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.78","spread":"1.550"},{"groupId":"OG001","value":"13.00","spread":"1.489"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.04","spread":"1.644"},{"groupId":"OG001","value":"12.93","spread":"1.646"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hematology Parameter: Platelet Count","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"229.1","spread":"64.75"},{"groupId":"OG001","value":"229.0","spread":"63.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"230.5","spread":"65.20"},{"groupId":"OG001","value":"226.5","spread":"65.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"227.7","spread":"62.55"},{"groupId":"OG001","value":"227.6","spread":"64.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"228.4","spread":"60.29"},{"groupId":"OG001","value":"229.1","spread":"63.44"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Hematology Parameter: Leukocytes","description":"Changes from baseline to Day 5, Month 1 and Month 4; presented by treatment arm.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.53","spread":"1.576"},{"groupId":"OG001","value":"5.46","spread":"1.539"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.64","spread":"1.563"},{"groupId":"OG001","value":"5.60","spread":"1.507"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.51","spread":"1.446"},{"groupId":"OG001","value":"5.50","spread":"1.427"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.49","spread":"1.385"},{"groupId":"OG001","value":"5.52","spread":"1.426"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG (Electrocardiogram) Parameter: Heart Rate (HR)","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an analysis of covariance (ANCOVA) model adjusted for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.8","spread":"10.7"},{"groupId":"OG001","value":"70.0","spread":"12.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"66.4","spread":"9.9"},{"groupId":"OG001","value":"69.1","spread":"12.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"8.4"},{"groupId":"OG001","value":"-0.9","spread":"8.3"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG Parameter: RR Interval","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an ANCOVA model adjusted for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"921.6","spread":"143.8"},{"groupId":"OG001","value":"882.2","spread":"149.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"923.5","spread":"137.4"},{"groupId":"OG001","value":"893.7","spread":"149.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"103.5"},{"groupId":"OG001","value":"11.5","spread":"94.8"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG Parameter: PR Interval","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an ANCOVA model adjusted for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"162.4","spread":"25.2"},{"groupId":"OG001","value":"162.2","spread":"20.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"161.4","spread":"23.0"},{"groupId":"OG001","value":"161.9","spread":"20.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.0","spread":"1.11"},{"groupId":"OG001","value":"-0.3","spread":"12.8"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG Parameter: QRS Interval","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an ANCOVA model adjusting for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82.2","spread":"8.2"},{"groupId":"OG001","value":"82.3","spread":"10.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"81.8","spread":"8.4"},{"groupId":"OG001","value":"82.5","spread":"9.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"5.4"},{"groupId":"OG001","value":"0.3","spread":"4.5"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG Parameter: QT Interval","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an ANCOVA model adjusted for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"389.5","spread":"27.8"},{"groupId":"OG001","value":"383.0","spread":"33.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"377.3","spread":"26.7"},{"groupId":"OG001","value":"383.1","spread":"30.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.1","spread":"21.4"},{"groupId":"OG001","value":"0.1","spread":"20.4"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG Parameter: QTcF","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an ANCOVA model adjusted for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"401.3","spread":"20.0"},{"groupId":"OG001","value":"400.5","spread":"24.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"388.5","spread":"20.5"},{"groupId":"OG001","value":"399.0","spread":"21.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.8","spread":"13.3"},{"groupId":"OG001","value":"-1.5","spread":"13.8"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in ECG Parameter: QTcB","description":"Actual values at baseline (Day 1 pre-dose) and Day 5. Change from baseline at Day 5 (Δ). Placebo-corrected change from baseline (ΔΔ), calculated using an ANCOVA model adjusted for sex and age.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"407.9","spread":"23.0"},{"groupId":"OG001","value":"410.1","spread":"25.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"394.6","spread":"23.3"},{"groupId":"OG001","value":"407.8","spread":"24.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.3","spread":"14.2"},{"groupId":"OG001","value":"-2.3","spread":"14.8"}]}]}]},{"type":"SECONDARY","title":"Placebo-corrected Baseline-adjusted QTcF (ΔΔQTcF), Computed From a Concentration-response (C-R) Model Between Dry Blood Spot Concentration and Changes From Baseline in QTcF Parameter","description":"Mixed linear model developed based on the model defined by Garnett et al (2017).\n\nThe fixed effect parameters of the pre-specified model were intercept, slope for acoziborole concentrations, influence of baseline (centered on mean), and a treatment specific intercept (0=acoziborole, 1=Placebo). Sex and age were included in the model as fixed covariates.","paramType":"MEAN","dispersionType":"90% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Abnormal Values for PR, QRS, QTcB and QTcF According to Pre-defined Thresholds","description":"Incidence of abnormal values for PR, QRS, QTcB and QTcF at Day 1 and/or Day 5, according to pre-defined thresholds","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of Severe Treatment-related TEAEs","description":"Occurrence and excess rate (95% CI) of any serious TEAEs.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of Any Treatment-related TEAEs","description":"Occurrence of any treatment-related TEAEs by arm","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]}]},{"type":"PRIMARY","title":"Occurrence of Treatment-related TEAEs by PT","description":"Occurrence of any treatment-related TEAEs by PT and by arm","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":906},"commonTop":["Headache","Malaria","Abdominal pain","Fatigue","Acarodermatitis"]}}}